EGFR mutation status in a series of Turkish non-small cell lung cancer patients-Reference-Cited by-同舟云学术

EGFR mutation status in a series of Turkish non-small cell lung cancer patients

Published:2020-06-02 Issue: Volume: Page:
ISSN:2049-9434
Container-title:Biomedical Reports
language:
Short-container-title:biom rep

Author:

Calibasi-Kocal Gizem¹,Amirfallah Arsalan²,Sever Tolga¹,Umit Unal Olcun³,Gurel Duygu⁴,Oztop Ilhan⁵,Ellidokuz Hulya⁶,Basbinar Yasemin¹

Affiliation:

1. Department of Translational Oncology, Institute of Oncology, Dokuz Eylul University, Izmir 35340, Turkey

2. Biomedical Center, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland

3. Bozyaka Education and Research Hospital, Division of Medical Oncology, Department of Internal Medicine, University of Health Sciences, Izmir 35170, Turkey

4. Departments of Pathology and Medical Oncology, Faculty of Medicine, Dokuz Eylul University, Izmir 35340, Turkey

5. Departments of Medical Oncology, Faculty of Medicine, Dokuz Eylul University, Izmir 35340, Turkey

6. Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, Izmir 35340, Turkey

Publisher

Spandidos Publications

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Epidermal Growth Factor, Anaplastic Lymphoma Kinase, and ROS Proto-oncogene 1 Mutation Profile of Non-Small Cell Lung Carcinomas in the Turkish Population: A Single-Center Analysis;Thoracic Research and Practice;2024-02-09

2. Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based Idylla^TM System;Cancer Control;2023-04

3. Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer;Balkan Journal of Medical Genetics;2022-12-01

4. Lung Cancer in Turkey;Journal of Thoracic Oncology;2022-10

5. Effects of EGFR gene mutation on stage 3A lung adenocarcinomas in the clinical decision-making process for mediastinal invasive staging;Medical Science and Discovery;2022-01-24